The European Union has struck a deal for up 405 million doses of German biotech firm CureVac's potential Covid-19 vaccine, the head of the EU executive has said, taking total supplies secured by the bloc to nearly two billion doses.
The deal with CureVac follows EU supply agreements with AstraZeneca, Johnson & Johnson, Sanofi, and Pfizer for a combined 1.4 billion doses of their potential vaccines. "I am glad to announce a new agreement to buy up to 405 million doses of a vaccine produced by the European company CureVac," European Commission President Ursula von der Leyen said, adding the contract was negotiated after EU funding to the company to develop its vaccine.
Read more on rte.ie